Cresco Labs Inc. (CRLBF) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.02 per share a year ago. These figures ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Cresco Labs Inc. (CRLBF) is a stock that can certainly grab the attention of many ...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands ...

Cresco Labs Inc. reported an ugly Q1 2023 with revenues falling 10% YoY. This MSO is likely to languish due to the Columbia Care merger struggling to complete divestitures needed for regulatory ...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands ...

Cresco Labs Inc.'s share price is not expected to significantly increase due to uncertainty in the US cannabis industry and lack of federal legislation and changes to rules and regulations. The ...

Earnings call Cresco Labs reported Q2 2025 revenue of $164M, down 1% sequentially, with adjusted EBITDA of $41M (25% margin). The company secured a $325M debt refinancing through 2030 and is ...

Cresco Labs Inc.’s stock rallied Wednesday after the Chicago-based cannabis company said it swung to a fourth-quarter profit on stronger-than-expected revenue. Cresco Labs CRLBF said it earned $4.87 ...

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of ...

Earnings call Cresco Labs reported Q3 2025 revenue of $165M, up 1% sequentially, with adjusted EBITDA of $40M (24% margin). Wholesale strength offset retail softness. Management reaffirmed stable Q4 ...